Milestone Investment Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-203
Closed -$18.5K 446
2023
Q1
$18.5K Buy
+203
New +$18.5K 0.01% 268